Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Glob Health Action ; 11(1): 1510593, 2018.
Article in English | MEDLINE | ID: mdl-30191749

ABSTRACT

BACKGROUND: In Myanmar, HIV seropositive children are being enrolled in an integrated HIV care (IHC) Program for HIV treatment and care since 2005. OBJECTIVES: To assess the: (a) attrition (death or loss-to-follow-up) rates among children (aged ≥ 18 months to < 15 years) enrolled into the programme before and after initiation of anti-retroviral therapy (ART) (pre-ART and ART periods); (b) demographic and clinical factors associated with attrition during these two periods. METHODS: Children enrolled in IHC Programme and their status (death, lost to follow-up, regular follow-up or transferred out) was assessed as on 30 June 2017. Attrition rates (per 100 person-years) at pre - ART and ART periods were calculated and the association between demographic and clinical characteristics with attrition was assessed using Cox proportional hazards model. RESULTS: Among 2,736 children enrolled, pre-ART attrition rate was 19 per 100 person-years of follow-up (95% CI: 17-21) and ART attrition rate was 4 per 100 person-years of follow-up (95% CI: 3-4) with higher levels during the initial few months of enrolment. The 36-month retention rates during pre-ART period was 75% (95% CI: 72-78) and during ART period was 87% (95% CI: 86-88). The children 'at enrolment' with relatively lower levels of haemoglobin, immune deficiency, underweight for age, higher WHO clinical stages, presence of hepatitis B infection had higher hazards of attrition in both periods. CONCLUSION: The attrition rates are high particularly among children with relatively poorer clinical, nutritional profiles at enrolment. The study suggests the urgent need for improving adherence counselling especially during the initial few months of enrolment and early ART initiation.


Subject(s)
Anti-HIV Agents/therapeutic use , HIV Infections/drug therapy , Lost to Follow-Up , Adolescent , Anti-HIV Agents/administration & dosage , CD4 Lymphocyte Count , Child , Child, Preschool , Cohort Studies , Female , HIV Infections/therapy , Health Status , Humans , Infant , Male , Myanmar/epidemiology , Proportional Hazards Models , Socioeconomic Factors , Thinness
SELECTION OF CITATIONS
SEARCH DETAIL
...